Previously, it was thought that phosphorylation at Y307 on PP2Ac was also related to cancer progression and PP2A inhibition; however, recent validation experiments on the p-Y703 antibody have shown a lack of specificity towards this residue. This evidence concerns the gene PTPA and cancer.